0
Skip to Content
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data Commons
BLOODPAC Data Commons
BLOODPAC Discovery Portal
Recommended Preanalytical Data Elements
Data Model & Governance
Data Commons FAQs
Impact
Frameworks & Standards
BLOODPAC Publications
Member Publications
BLOODPAC Events
Resources
Insights
Videos
MEMBER LOGIN
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data Commons
BLOODPAC Data Commons
BLOODPAC Discovery Portal
Recommended Preanalytical Data Elements
Data Model & Governance
Data Commons FAQs
Impact
Frameworks & Standards
BLOODPAC Publications
Member Publications
BLOODPAC Events
Resources
Insights
Videos
MEMBER LOGIN
Folder: About
Back
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Folder: Approach
Back
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Folder: Data Commons
Back
BLOODPAC Data Commons
BLOODPAC Discovery Portal
Recommended Preanalytical Data Elements
Data Model & Governance
Data Commons FAQs
Folder: Impact
Back
Frameworks & Standards
BLOODPAC Publications
Member Publications
BLOODPAC Events
Folder: Resources
Back
Insights
Videos
MEMBER LOGIN
Understanding Molecular Residual Disease (MRD) in Solid Tumors
Liquid Biopsy Technology Guest User 3/13/23 Liquid Biopsy Technology Guest User 3/13/23

Understanding Molecular Residual Disease (MRD) in Solid Tumors

Read More
Understanding Tumor Mutational Burden (TMB)
Liquid Biopsy Technology Guest User 3/7/23 Liquid Biopsy Technology Guest User 3/7/23

Understanding Tumor Mutational Burden (TMB)

Read More
Contrived Materials in Liquid Biopsy Assay Development
Liquid Biopsy Technology Guest User 2/27/23 Liquid Biopsy Technology Guest User 2/27/23

Contrived Materials in Liquid Biopsy Assay Development

Read More

ABOUT

BLOODPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based 501 (c)(3) not-for-profit corporation. Our mandate is to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer. To do so we developed the BLOODPAC Data Commons that enables sharing of information between stakeholders in industry, academia, and regulatory agencies.